EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cardiovascular toxicity induced by immune checkpoint inhibitors: mechanisms linking immune dysregulation and myocardial fibrosis

Di Wang, Bin-Kui Jia, Zhao-Yu Li, Qian Qiao, Lu Cheng, Li-Hong Zhang, Xue-Rui Ye, Hao-Ling Zhang, Jing-Jing Zhang

American Journal of Clinical and Experimental Immunology · 2026 · 15 (3) · 203-227

DOI: 10.62347/mtax7470 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2026. Verfasst von Di Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia Penang 13200, Malaysia. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) play a key role in cancer immunotherapy, enhancing outcomes for patients with multiple malignancies by blocking the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) pathways. Nevertheless, their application is limited due to immune-related adverse events (irAEs), which comprise various manifestations, among which cardiovascular toxicities - primarily myocarditis, arrhythmias, pericarditis, and heart failure - are a major clinical challenge. While relatively rare, myocarditis has a fatality rate as high as 50%. The mechanisms underlying ICI-induced cardiovascular toxicity remain not fully understood, especially regarding how immune dysregulation translates into myocardial fibrosis. Herein, the immune dysregulation-inflammation-fibrosis axis is reviewed, and the mechanisms by which immune checkpoint blockade breaks cardiac immune tolerance, inducing T-cell activation, cytokine storms, and the subsequent production of anti-cardiac antibodies, are discussed. Moreover, the important function of non-coding RNAs (ncRNAs) in immunomodulatory and fibrotic pathways is then revealed as a key player in ICI-associated cardiac injury. It also discusses therapeutic strategies involving immune modulation and anti-fibrotic mechanisms, which may be suitable to reduce cardiovascular toxicity as well as improve the overall prognosis of patients. An improved mechanistic understanding underlying these processes will offer new theoretical insights into how to most effectively utilize ICIs safely.

Schlagwörter

Stichwörter der Autor:innen

Immune checkpoint inhibitorscardiovascular toxicityimmune dysregulationmyocardial fibrosismyocarditisnon-coding RNAs

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia Penang 13200, Malaysia.
  • Clinical College of Traditional Chinese Medicine, Gansu University of Chinese Medicine Lanzhou 730000, Gansu, China.
  • College of Acupuncture-Moxibustion and Tuina, Gansu University of Chinese Medicine Lanzhou 730000, Gansu, China.
  • Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University Kunming 650000, Yunnan, China.
  • Yunnan Provincial Cardiovascular Clinical Medical Center Kunming 650000, Yunnan, China.
  • Yunnan Provincial Cardiovascular Clinical Medical Research Center Kunming 650000, Yunnan, China.

Zitieren

APA

Wang, D., Jia, B. K., Li, Z. Y., Qiao, Q., Cheng, L., Zhang, L. H., Ye, X. R., Zhang, H. L., & Zhang, J. J. (2026). Cardiovascular toxicity induced by immune checkpoint inhibitors: mechanisms linking immune dysregulation and myocardial fibrosis. American Journal of Clinical and Experimental Immunology, 15(3), 203-227. https://doi.org/10.62347/mtax7470

Vancouver

Wang D, Jia BK, Li ZY, Qiao Q, Cheng L, Zhang LH, et al. Cardiovascular toxicity induced by immune checkpoint inhibitors: mechanisms linking immune dysregulation and myocardial fibrosis. American Journal of Clinical and Experimental Immunology. 2026;15(3):203-227. doi:10.62347/mtax7470

BibTeX
@article{Wang2026,
  author = {Wang, Di and Jia, Bin-Kui and Li, Zhao-Yu and Qiao, Qian and Cheng, Lu and Zhang, Li-Hong and Ye, Xue-Rui and Zhang, Hao-Ling and Zhang, Jing-Jing},
  title = {Cardiovascular toxicity induced by immune checkpoint inhibitors: mechanisms linking immune dysregulation and myocardial fibrosis},
  journal = {American Journal of Clinical and Experimental Immunology},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {203--227},
  doi = {10.62347/mtax7470}
}
Kostenlos starten →